The RxISK Medical Team has posted a “final” copy of the RxISK Guide to Stopping Antidepressants. Thanks to all for your feedback on the Guide (originally published as a draft paper) and please continue to provide input for the next version. … [Read more...] about New Guide to Stopping Antidepressants
News
New Fundraising Initiative for RxISK.org
News Release New fundraising initiative launches this weekend in Hastings to highlight deadly anti-depressant drug side effects A new fundraising initiative is launching on Sunday March 23, 2014 to raise awareness of the potentially deadly side effects of anti-depressant drugs. RxISK.org is the first organisation of its kind to gather and disseminate information on the side … [Read more...] about New Fundraising Initiative for RxISK.org
The Right Stuff – The RxISK Stuff
Editorial Note: The RxISK Report function on RxISK has been streamlined. We want you and everyone who can to fill reports, take them to your doctor pharmacist or nurse prescriber and report back to us. There are two reasons to do so. First, you are getting $150.00 worth of RxISK Report for free - it seems a shame to leave it sitting on your computer doing nothing. Second, … [Read more...] about The Right Stuff – The RxISK Stuff
RxISK adds 320,172 Health Canada reports of adverse events to its drug safety database
Toronto, Ontario — September 26, 2013 – RxISK.org, the first free, independent website for researching and reporting prescription drug side effects, has added to its drug safety database more than 320,000 adverse drug events reported to Health Canada from 1965 to March 31, 2013. The RxISK database now has more than 4.8 million reports of suspected adverse drug events — as … [Read more...] about RxISK adds 320,172 Health Canada reports of adverse events to its drug safety database
RxISK drug safety petition asks AbbVie and InterMune to stop blocking access to drug clinical trial data
Toronto, Ontario — September 13, 2013 – RxISK.org, the first free, independent website for researching and reporting prescription drug side effects, has launched a drug safety petition asking two pharmaceutical giants to stop blocking the European Medicines Agency (EMA) from releasing prescription drug clinical trial data. In 2010, the EMA began releasing patient-level data … [Read more...] about RxISK drug safety petition asks AbbVie and InterMune to stop blocking access to drug clinical trial data
RxISK Seeks Reports from AbbVie Customers
Are you taking any AbbVie drugs? David Healy & team want a report from you at RxISK.org Toronto, Ontario — July 15, 2013 – RxISK.org, the first free independent website for researching and reporting prescription drug side effects, is helping a campaign to capture patient reported side effects of a range of drugs sold by the pharmaceutical company AbbVie (NYSE:ABBV) - the … [Read more...] about RxISK Seeks Reports from AbbVie Customers
RxISK on track for world record for patient reported side effects
No one knows a drug’s side effects like the person taking it and that's why RxISK.org has been created to provide a place where patients can research, report, and share their stories with others. More patients are now reporting side effects to RxISK than to country regulators. News release RxISK.org, the first free independent website for researching and reporting … [Read more...] about RxISK on track for world record for patient reported side effects
RxISK Establishes Charitable Funds in US, UK, & Canada
RxISK.org, the first free independent website for researching and reporting prescription drug side effects, has established RxISK Funds in the United States, United Kingdom, and Canada. Each RxISK Fund is used to support global prescription drug safety. Receipts for US tax purposes, UK, or Canadian purposes are issued for donations. These funds have been established within … [Read more...] about RxISK Establishes Charitable Funds in US, UK, & Canada
RxISK Announces New Tools to Decipher Drug Company Speak
RxISK.org, the first free independent website for researching and reporting prescription drug side effects, is adding two enhancements in the first week of June. Researchers will be able to access patient stories and the official assessment of side effect causality. RxISK stories Narratives shared by patients with their permission and without personal identifiers, will now be … [Read more...] about RxISK Announces New Tools to Decipher Drug Company Speak
Daily Mail Online: What is wrong with randomised trials Part 2
May 5, 2013 By Jerome Burne Could alcohol get a licence as a drug for depression? How do you test for the safety of a drug that causes the same side effects as the disease it is used to treat? These are just two of the points I didn’t have room for in my post last week on randomised controlled trials (RCTs) and why they don’t tell you what you want to know. (More on these … [Read more...] about Daily Mail Online: What is wrong with randomised trials Part 2